Halozyme Therapeutics
HALO
#2006
Rank
NZ$13.62 B
Marketcap
$110.28
Share price
1.86%
Change (1 day)
62.83%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): NZ$0.93 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are NZ$1.01 Billion. , an increase over its 2023 earnings that were of NZ$0.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.97 B59.94%
2023 NZ$0.60 B39.94%
2022 NZ$0.43 B0.16%
2021 NZ$0.43 B92.2%
2020 NZ$0.22 B-278.96%
2019 -NZ$0.13 Billion-9.45%
2018 -NZ$0.14 Billion-229.51%
2017 NZ$0.10 B-160.48%
2016 -NZ$0.18 Billion216.03%
2015 -NZ$56.41 Million-52.86%
2014 -NZ$0.12 Billion-18.09%
2013 -NZ$0.15 Billion55.88%
2012 -NZ$93.72 Million169.94%
2011 -NZ$34.72 Million-63.44%
2010 -NZ$94.96 Million-7.19%
2009 -NZ$0.11 Billion15.91%
2008 -NZ$88.27 Million83.89%
2007 -NZ$48 Million78.1%
2006 -NZ$26.96 Million16%
2005 -NZ$23.24 Million45.24%
2004 -NZ$16 Million682.42%
2003 -NZ$2.05 Million1659.12%
2002 -NZ$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$53.4 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.19 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.04 Billion-206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.44 B 1,894.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.89 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$30.52 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA